The impact of metabolic syndrome on carotid intima media thickness

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 17, 2013, Pages 2295-2301

  Aydin, M ^a   Bulur, S ^b   Alemdar, R ^c   Yalcin S ^b   Turker Y ^b   Basar, C ^b   Aslantas, Y ^b   Yazgan, O ^d   Albayrak, S ^b   Ozhan H ^b  

^a DICLE UNIVERSITY   (Turkey)

^b DUZCE UNIVERSITY   (Turkey)

^c ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d Duzce Ataturk State Hospital   (Turkey)

Author keywords

Carotid intima media thickness; Metabolic Syndrome

Indexed keywords

CHOLESTEROL; ELECTROLYTE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DIASTOLIC BLOOD PRESSURE; ELECTROLYTE BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; QUESTIONNAIRE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OBESITY, MORBID; OVERWEIGHT; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84884258267     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. GRUNDY SM, CLEEMAN JI, DANIELS SR, DONATO KA, ECKEL RH, FRANKLIN BA, GORDON DJ, KRAUSS RM, SAVAGE PJ, SMITH SC JR, SPERTUS JA, COSTA F; AMERICAN HEART ASSOCIATION; NATIONAL HEART, LUNG; BLOOD INSTITUTE. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
2. MIKHAIL N. The metabolic syndrome: insulin resistance. Curr Hypertens Rep 2009; 11: 156-158.
3. BONORA E, KIECHL S, WILLEIT J, OBERHOLLENZER F, EGGER G, BONADONNA RC, MUGGEO M. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care 2003; 26: 1251-1257.
4. ND, BIELAK LF. Association between metabolic syndrome and subclinical coronary atherosclerosis in asymptomatic adults. Am J Cardiol 2004; 94: 1554-1558.
5. FORD ES, GILES WH, DIETZ WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
6. KARELIS AD, BROCHU M, RABASA-LHORET R. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab 2004; 30: 569-572.
7. KARELIS AD, FARAJ M, BASTARD JP, ST-PIERRE DH, BROCHU M, PRUD'HOMME D, RABASA-LHORET R. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005; 90: 4145-4150.
8. PRIMEAU V, CODERRE L, KARELIS AD, BROCHU M, LAVOIE ME, MESSIER V, SLADEK R, ET AL. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 2011; 35: 971-981.
9. PARK YW, ZHU S, PALANIAPPAN L, HESHKA S, CARNETHON MR, HEYMSFIELD SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003; 163: 427-436.
10. CALORI G, LATTUADA G, PIEMONTI L, GARANCINI MP, RAGOGNA F, VILLA M, MANNINO S, CROSIGNANI P, BOSI E, LUZI L, RUOTOLO G, PERSEGHIN G. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 2011; 34:210-215.
11. KUK JL, ARDERN CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 2009; 32: 2297-2299.
12. MEIGS JB, WILSON PW, FOX CS, VASAN RS, NATHAN DM, SULLIVAN LM, D'AGOSTINO RB. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006; 91: 2906-2912.
13. ST-PIERRE AC, CANTIN B, MAURIEGE P, BERGERON J, DAGENAIS GR, DESPRES JP, LAMARCHE B. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ 2005; 172: 1301-1305.
14. MONTAUBAN VAN SWIJNDREGT AD, DE LANGE EE, DE GROOT E, ACKERSTAFF RG. An in vivo evaluation of the reproducibility of intima-media thickness measurements of the carotid artery segments using B-mode ultrasound. Ultrasound Med Biol 1999; 25: 323-330.
15. CLINICAL GUIDELINES ON THE IDENTIFICATION, EVALUATION, AND TREATMENT OF OVERWEIGHT AND OBESITY IN ADULTS: EXECUTIVE SUMMARY. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr 1998; 68: 899-917.
16. BASEVI V, DI MARIO S, MORCIANO C, NONINO F, MAGRINI N. Comment on: American Diabetes Association. Standards of medical care in diabetes - 2011. Diabetes Care 2011; 34(Suppl. 1): S11-S61. Diabetes Care 2011; 34: e53.
17. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
18. GRUNDY SM, BREWER HB, JR., CLEEMAN JI, SMITH SC, JR., LENFANT C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438.
19. ONAT A, UYAREL H, HERGENC G, KARABULUT A, ALBAYRAK S, CAN G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis 2007; 191: 182-190.
20. KAWAMOTO R, OHTSUKA N, NINOMIYA D, NAKAMURA S. Carotid atherosclerosis in normal-weight metabolic syndrome. Intern Med 2007; 46: 1771-1777.
21. TZOU WS, DOUGLAS PS, SRINIVASAN SR, BOND MG, TANG R, CHEN W, BERENSON GS, et al. Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study. J Am Coll Cardiol 2005; 46: 457-463.
22. LAAKSO M. Insulin resistance and coronary heart disease. Curr Opin Lipidol 1996; 7: 217-226.
23. STEFAN N, KANTARTZIS K, MACHANN J, SCHICK F, THAMER C, RITTIG K, BALLETSHOFER B, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008; 168: 1609-1616.
24. LIND L, SIEGBAHN A, INGELSSON E, SUNDSTROM J, ARNLOV J. A detailed cardiovascular characterization of obesity without the metabolic syndrome. Arterioscler Thromb Vasc Biol 2011; 31: e27-34.
25. MONTALCINI T, GORGONE G, GAZZARUSO C, SESTI G, PERTICONE F, PUJIA A. Carotid atherosclerosis associated to metabolic syndrome but not BMI in healthy menopausal women. Diabetes Res Clin Pract 2007; 76: 378-382.
26. CAMHI SM, KATZMARZYK PT, BROYLES ST, SRINIVASAN SR, CHEN W, BOUCHARD C, BERENSON GS. Subclinical atherosclerosis and metabolic risk: role of body mass index and waist circumference. Metab Syndr Relat Disord 2011; 9: 119-125.